Atsuya Takeda

Professor

Keio University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Atsuya Takeda is a faculty member at Keio University in Japan. His research focuses on the application of stereotactic body radiotherapy in the treatment of various cancers, including colorectal cancer and non-small-cell lung cancer. He has published several articles examining the efficacy and outcomes of radiotherapy techniques, including the use of artificial neural networks to enhance decision-making in cancer treatment.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (2)

Noriko Kishi

Program-Specific Assistant Professor

Kyoto University Hospital

JAPAN

View details

Takafumi Nemoto

Keio University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Atsuya Takeda

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy

Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis

Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer

CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy

In Regard to Kim et al. and Ohri et al.

Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma

In Regard to Chang et al

Feasibility of marker-less stereotactic body radiotherapy for hepatocellular carcinoma

Impact of Local Recurrence on Cause-Specific Death After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Dynamic Prediction Using Landmark Model.

Collaborators (2)

Noriko Kishi

Takafumi Nemoto

Make your next move.